Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lean Technologies secures US$67.5M in Series B funding led by General Catalyst to expand its open banking infrastructure ...

Mineralys Therapeutics, Inc. ( (MLYS) ) has released its Q3 earnings. Here is a breakdown of the information Mineralys Therapeutics, Inc.

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

On-Demand Service Broker (ODB) BOSH Release, a BOSH-packaged-up framework for more easily developing OSBAPI-compliant service brokers that provision and deprovision new instances with BOSH ...

Cybersecurity, an area pivotal for companies implementing new technologies ... Creating an online account for a business that ...

Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...